Thrombolytic Therapy in Acute Myocardial Infarction
- 1 April 2000
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 16 (4) , 301-312
- https://doi.org/10.2165/00002512-200016040-00006
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: The ASSENT-1 trialAmerican Heart Journal, 1999
- A double-blind multicenter comparison of the efficacy and safety ofsaruplase andurokinase in thetreatment ofacutemyocardialinfarction: Report of the SUTAMI study groupJournal of Thrombosis and Thrombolysis, 1995
- Time as an adjunctive agent to thrombolytic therapyJournal of Thrombosis and Thrombolysis, 1994
- Thrombolysis following pre-hospital cardiopulmonary resuscitationInternational Journal of Cardiology, 1992
- Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarctionThe American Journal of Cardiology, 1990
- Thrombolytic Therapy: Current StatusNew England Journal of Medicine, 1988
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- Intravenous urokinase in acute myocardial infarctionThe American Journal of Cardiology, 1985
- The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs.Circulation, 1977
- StreptokinaseDrugs, 1973